Ragnar E. Löfstedt - Publications, H-index & Citations

Ragnar E. Löfstedt

Linnaeus University

35H指数

191论文数

4.5K被引数

收录论文 40

发表时间

Learning from Behavioural Changes That Fail

TRENDS IN COGNITIVE SCIENCES

IF17.2

2020-12-01

OAAI

Osman, Magda; McLachlan, Scott; Fenton, Norman; Neil, Martin; Lofstedt, Ragnar; Meder, Bjoern

Pharmaceutical Benefit-Risk Perception and Age Differences in the USA and Germany

DRUG SAFETY

IF3.8

2020-07-23

PREAI

Balog-Way, Dominic H. P.; Evensen, Darrick; Lofstedt, Ragnar E.

Communicating to and engaging with the public in regulatory science 与公众沟通并参与监管科学

EFSA JOURNAL

IF3.3

2019-07-01

OAAI

Smith, Anthony; Parrino, Lucia; Vrbos, Domagoj; Nicolini, Giulia; Bucchi, Massimiano; Carr, Melanie; Chen, Junshi; Dendler, Leonie; Krishnaswamy, Kannan; Lecchini, Davide; Lofstedt, Ragnar; Patel, Michelle; Reisch, Lucia; Verloo, Didier; Vos, Ellen; Zollo, Fabiana; Gallani, Barbara

Anticipating or Accommodating to Public Concern? Risk Amplification and the Politics of Precaution Reexamined 预期或适应公众的关注？风险放大与防范政治的重新审视

RISK ANALYSIS

IF3.3

2018-04-26

OAAI

Wardman, Jamie K.; Lofstedt, Ragnar

The problems of increasing transparency on uncertainty

PUBLIC UNDERSTANDING OF SCIENCE

IF3.3

2017-05-23

OAAI

Osman, Magda; Heath, Amanda J.; Lofstedt, Ragnar

Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature

DRUG SAFETY

IF3.8

2016-10-14

PREAI

Way, Dominic; Blazsin, Hortense; Lofstedt, Ragnar; Bouder, Frederic

HOW RISKS ARE PERCEIVED. RECENT RESEARCH FINDINGS

CLINICAL THERAPEUTICS

IF3.6

2015-08-01

PREAI

Way, D.; Bouder, F.; Lofstedt, R.

Transparency in Europe: A Quantitative Study

RISK ANALYSIS

IF3.3

2015-05-01

OAAI

Bouder, Frederic; Way, Dominic; Loefstedt, Ragnar; Evensen, Darrick

Response to Commentaries

RISK ANALYSIS

IF3.3

2013-07-08

PREAI

Loefstedt, Ragnar E.

The Informal European Parliamentary Working Group on RiskHistory, Remit, and Future Plans: A Personal View

RISK ANALYSIS

IF3.3

2013-05-08

PREAI

Loefstedt, Ragnar E.

Transparency and the Food and Drug Administration-A Quantitative Study

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2013-04-01

PREAI

Lofstedt, Ragnar; Bouder, Frederic; Chakraborty, Sweta

Improving the Decision-Making Process for Nonprescription Drugs: A Framework for Benefit-Risk Assessment

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2011-11-02

PREAI

Brass, E. P.; Lofstedt, R.; Renn, O.

Communicating Food Risks in an Era of Growing Public Distrust: Three Case Studies 在公众日益不信任的时代传播食品风险: 三个案例研究

RISK ANALYSIS

IF3.3

2011-11-02

PREAI

Lofstedt, Ragnar

Nanotechnology Risk Communication Past and Prologue 纳米技术风险沟通的过去和序幕

RISK ANALYSIS

IF3.3

2010-10-29

OAAI

Bostrom, Ann; Loefstedt, Ragnar E.

Nano Risk Analysis: Advancing the Science for Nanomaterials Risk Management

RISK ANALYSIS

IF3.3

2010-09-15

PREAI

Shatkin, Jo Anne; Abbott, Linda Carolyn; Bradley, Ann E.; Canady, Richard Alan; Guidotti, Tee; Kulinowski, Kristen M.; Loefstedt, Ragnar E.; Louis, Garrick; MacDonell, Margaret; Maynard, Andrew D.

Use of risk assessment and life cycle assessment in decision making: A common policy research agenda

RISK ANALYSIS

IF3.3

2008-09-02

PREAI

Cowell, SJ; Fairman, R; Lofstedt, RE

Are renewables an alternative to nuclear power? An analysis of the Austria/Slovakia discussions

ENERGY POLICY

IF9.2

2008-06-01

PREAI

Lofstedt, Ragnar